SAB——一种有望提高老年急性髓系白血病缓解率的新疗法？
SAB--a promising new treatment to improve remission rates in AML in the elderly?
作者信息
Wheatley Keith
机构信息
University of Birmingham Clinical Trials Unit, Park Grange, 1 Somerset Road, Edgbaston, Birmingham B15 2RR, UK.
出版信息
Br J Haematol. 2002 Aug;118(2):432-3. doi: 10.1046/j.1365-2141.2002.03620.x.
Abstract
This short report presents the results of a comparison of complete remission rates and reasons for failure, between two series of patients aged 60 years or over with acute myeloid leukaemia (AML), and discusses their interpretation.
摘要
本简短报告展示了两组60岁及以上急性髓系白血病（AML）患者完全缓解率及失败原因的比较结果，并对其解读进行了讨论。
Zotero 插件